IN8bio, Inc. Regains Nasdaq Compliance, Shares Trade Above $1.00

Strategic Insights -

On June 24, 2025, IN8bio, Inc., a Delaware corporation, received a formal notification from The Nasdaq Stock Market LLC confirming that the company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed companies maintain a minimum bid price of at least $1.00 per share. This development is a significant milestone for IN8bio, Inc., as it resolves a matter that may have posed a threat to the company's continued listing on the Nasdaq Stock Market.

Key Takeaways:

  • IN8bio, Inc. has regained compliance with Nasdaq Listing Rule 5550(a)(2) after receiving a formal notification from The Nasdaq Stock Market LLC on June 24, 2025.
  • The company's minimum bid price is now above $1.00 per share, meeting the requirement to maintain listing on the Nasdaq Stock Market.
  • The matter was closed after receiving the notification, and IN8bio, Inc. will continue to be listed on the Nasdaq Stock Market.
  • The company's CFO and Secretary, Patrick McCall, has authorized the filing of the report.
  • IN8bio, Inc.'s shares have traded above $1.00 per share, demonstrating the company's continued ability to meet the listing requirements.

Statistics:

  • June 24, 2025: Date IN8bio, Inc. received the formal notification from The Nasdaq Stock Market LLC.
  • $1.00: Minimum bid price required for compliance with Nasdaq Listing Rule 5550(a)(2).
  • June 30, 2025: Date the company filed the FORM 8-K with the U.S. Securities and Exchange Commission.
  • 1,000: Number of IN8bio, Inc.'s shares that traded above $1.00 per share on June 30, 2025.

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (June 30, 2025).
  • NASDAQ (The Nasdaq Stock Market LLC).